Enhanced Slin 120 Capsules | Glucose Disposal Agent
Glucose Disposal Agents, also referred to as GDA's or Insulin Mimetics are a fast growing category of the supplement space. These supplements are powerful carbohydrate catalysts which help the body shuttle carbs to the muscles to be used as energy as opposed to being turned into fat. Enhanced Slin was formulated for that exact reason, to put carbs into your muscles. Slin is great for those bulking or to take before a cheat meal. Grab yourself a bottle and experience the difference for yourself!
Enhanced Slin GDA Supplement Product Highlights
- All New Glucose Disposal Agent
- Helps With Nutrient Partitioning
- Powerful Carbohydrate Catalyst
- Unique Insulin Mimetic That Shuttles Carbs to Muscles
- Increased Muscle Pumps
- Lower Insulin Response & Enhanced Fat Loss
- Great for Cheat Days or Heavy Carb Meals
- Fully Transparent, No Proprietary Blends
Directions
Take 4 capsules 1-2 times per day with your highest carb meal of the day.
Enhanced Slin 120 Capsules Ingredients & Supplement Facts
Serving Size: 4 Capsules
Servings Per Container: 30
Chromium 200mcg
Bitter Melon Extract 300mg
Berberine Hydrochloride 300mg
Cinnamon Extract 200mg
Alpha Lipoic Acid 150mg
Fenegreek Extract 150mg
Kaempferol 150mg
Myricetin 90mg
Banaba Powder 90mg
African Mango Extract 50mg
Fluxoxanthin 8mg
Other Ingredients: Gelatin (Titanium Dioxide, FD&C Blue #1, FD&C Yellow #5, FD&C Yellow #6, Dicalcium Phosphate, Silicon Dioxide, Magnesium Stearate.
Warnings
Store in a cool dry place after opening.
References
Jacob S, Henriksen EJ, Schiemann AL, Simon I, Clancy DE, Tritschler HJ, Jung WI, Augustin HJ, Dietze GJ. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung. 1995 Aug;45(8):872-4. PMID: 7575750.
https://pubmed.ncbi.nlm.nih.gov/7575750/
Reynolds TH 4th, Supiano MA, Dengel DR. Resistance training enhances insulin-mediated glucose disposal with minimal effect on the tumor necrosis factor-alpha system in older hypertensives. Metabolism. 2004 Mar;53(3):397-402. doi: 10.1016/j.metabol.2003.09.017. PMID: 15015154.
https://pubmed.ncbi.nlm.nih.gov/15015154/
Toth MJ, Sites CK, Cefalu WT, Matthews DE, Poehlman ET. Determinants of insulin-stimulated glucose disposal in middle-aged, premenopausal women. Am J Physiol Endocrinol Metab. 2001 Jul;281(1):E113-21. doi: 10.1152/ajpendo.2001.281.1.E113. PMID: 11404228.
https://pubmed.ncbi.nlm.nih.gov/11404228/
†We make every effort to ensure that the product images displayed on our website faithfully represent what you will receive. However, we recognize that digital representations can sometimes fall short of capturing every nuance of the product's physical attributes. Differences in color, size, and packaging details might exist. To mitigate this, we advise our valued customers to delve into the product descriptions where the specific features, ingredients, and usage instructions of each product are meticulously outlined. This approach helps bridge the gap between expectation and reality, ensuring you are fully informed about your purchase.
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to treat, cure, diagnose, or prevent any disease.
